126 related articles for article (PubMed ID: 24612767)
1. Discovery of novel secretory phospholipase A2 inhibitors using virtual screen.
Qiu S; Chen F; Liu Y; Lai L
Chem Biol Drug Des; 2014 Aug; 84(2):216-22. PubMed ID: 24612767
[TBL] [Abstract][Full Text] [Related]
2. Targeting human secretory phospholipase A2 with designed peptide inhibitors for inflammatory therapy.
Wang P; Li Y; Shao Q; Zhou W; Wang K
J Drug Target; 2015 Feb; 23(2):140-6. PubMed ID: 25237841
[TBL] [Abstract][Full Text] [Related]
3. Virtual analysis of structurally diverse synthetic analogs as inhibitors of snake venom secretory phospholipase A2.
Sivaramakrishnan V; Ilamathi M; Ghosh KS; Sathish S; Gowda TV; Vishwanath BS; Rangappa KS; Dhananjaya BL
J Mol Recognit; 2016 Jan; 29(1):22-32. PubMed ID: 26218369
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological evaluation and docking studies of α,β-unsaturated carbonyl based synthetic compounds as inhibitors of secretory phospholipase A₂, cyclooxygenases, lipoxygenase and proinflammatory cytokines.
Bukhari SN; Lauro G; Jantan I; Bifulco G; Amjad MW
Bioorg Med Chem; 2014 Aug; 22(15):4151-61. PubMed ID: 24938495
[TBL] [Abstract][Full Text] [Related]
5. Studies of synthetic chalcone derivatives as potential inhibitors of secretory phospholipase A2, cyclooxygenases, lipoxygenase and pro-inflammatory cytokines.
Jantan I; Bukhari SN; Adekoya OA; Sylte I
Drug Des Devel Ther; 2014; 8():1405-18. PubMed ID: 25258510
[TBL] [Abstract][Full Text] [Related]
6. Computer-aided drug design guided by hydrogen/deuterium exchange mass spectrometry: A powerful combination for the development of potent and selective inhibitors of Group VIA calcium-independent phospholipase A
Mouchlis VD; Morisseau C; Hammock BD; Li S; McCammon JA; Dennis EA
Bioorg Med Chem; 2016 Oct; 24(20):4801-4811. PubMed ID: 27320659
[TBL] [Abstract][Full Text] [Related]
7. Discovery of a novel pyrazole series of group X secreted phospholipase A2 inhibitor (sPLA2X) via fragment based virtual screening.
Chen H; Knerr L; Åkerud T; Hallberg K; Öster L; Rohman M; Österlund K; Beisel HG; Olsson T; Brengdhal J; Sandmark J; Bodin C
Bioorg Med Chem Lett; 2014 Nov; 24(22):5251-5. PubMed ID: 25316315
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of secreted phospholipase A2 suppress the release of PGE2 in renal mesangial cells.
Vasilakaki S; Barbayianni E; Magrioti V; Pastukhov O; Constantinou-Kokotou V; Huwiler A; Kokotos G
Bioorg Med Chem; 2016 Jul; 24(13):3029-3034. PubMed ID: 27234891
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of novel 2-pyrazoline analogues with potent anti-inflammatory effect mediated by inhibition of phospholipase A2: Crystallographic, in silico docking and QSAR analysis.
Lokeshwari DM; Achutha DK; Srinivasan B; Shivalingegowda N; Krishnappagowda LN; Kariyappa AK
Bioorg Med Chem Lett; 2017 Aug; 27(16):3806-3811. PubMed ID: 28676270
[TBL] [Abstract][Full Text] [Related]
10. Recent failures in antiatherosclerotic drug development: examples from the thyroxin receptor agonist, the secretory phospholipase A2 antagonist, and the acyl coenzyme A: cholesterol acyltransferase inhibitor programs.
Stoekenbroek RM; Kastelein JJ; Hovingh GK
Curr Opin Lipidol; 2013 Dec; 24(6):459-66. PubMed ID: 24184941
[TBL] [Abstract][Full Text] [Related]
11. Structure-based grafting, mutation, and optimization of peptide inhibitors to fit in the active pocket of human secreted phospholipase A2: find new use of old Peptide agents with anti-inflammatory activity.
Zhan C; Li S; Zhong Q; Zhou D
Chem Biol Drug Des; 2015 Apr; 85(4):418-26. PubMed ID: 25187416
[TBL] [Abstract][Full Text] [Related]
12. Development of a potent 2-oxoamide inhibitor of secreted phospholipase A2 guided by molecular docking calculations and molecular dynamics simulations.
Vasilakaki S; Barbayianni E; Leonis G; Papadopoulos MG; Mavromoustakos T; Gelb MH; Kokotos G
Bioorg Med Chem; 2016 Apr; 24(8):1683-95. PubMed ID: 26970660
[TBL] [Abstract][Full Text] [Related]
13. Comparative studies on the inhibitory activities of selected benzoic acid derivatives against secretory phospholipase A2, a key enzyme involved in the inflammatory pathway.
Dileep KV; Remya C; Cerezo J; Fassihi A; Pérez-Sánchez H; Sadasivan C
Mol Biosyst; 2015 Jul; 11(7):1973-9. PubMed ID: 25927625
[TBL] [Abstract][Full Text] [Related]
14. Development of Potent and Selective Inhibitors for Group VIA Calcium-Independent Phospholipase A2 Guided by Molecular Dynamics and Structure-Activity Relationships.
Mouchlis VD; Limnios D; Kokotou MG; Barbayianni E; Kokotos G; McCammon JA; Dennis EA
J Med Chem; 2016 May; 59(9):4403-14. PubMed ID: 27087127
[TBL] [Abstract][Full Text] [Related]
15. Design and Amberlyst-15 mediated synthesis of novel thienyl-pyrazole carboxamides that potently inhibit Phospholipase A2 by binding to an allosteric site on the enzyme.
Kumar AD; Prabhudeva MG; Bharath S; Kumara K; Lokanath NK; Kumar KA
Bioorg Chem; 2018 Oct; 80():444-452. PubMed ID: 29986189
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of inhibition of human secretory phospholipase A2 by flavonoids: rationale for lead design.
Lättig J; Böhl M; Fischer P; Tischer S; Tietböhl C; Menschikowski M; Gutzeit HO; Metz P; Pisabarro MT
J Comput Aided Mol Des; 2007 Aug; 21(8):473-83. PubMed ID: 17701137
[TBL] [Abstract][Full Text] [Related]
17. Antisense inhibition of secretory and cytosolic phospholipase A2 reduces the mortality in rats with sepsis*.
Liu MS; Liu CH; Wu G; Zhou Y
Crit Care Med; 2012 Jul; 40(7):2132-40. PubMed ID: 22564957
[TBL] [Abstract][Full Text] [Related]
18. Design of new potent and selective secretory phospholipase A2 inhibitors. Part 5: synthesis and biological activity of 1-alkyl-4-[4,5-dihydro-1,2,4-[4H]-oxadiazol-5-one-3-ylmethylbenz-4'-yl(oyl)] piperazines.
Boukli L; Touaibia M; Meddad-Belhabich N; Djimdé A; Park CH; Kim JJ; Yoon JH; Lamouri A; Heymans F
Bioorg Med Chem; 2008 Feb; 16(3):1242-53. PubMed ID: 17993277
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and Biological Evaluation of Octahydroquinazolinones as Phospholipase A2, and Protease Inhibitors: Experimental and Theoretical Exploration.
Bakht MA; Pooventhiran T; Thomas R; Kamal M; Din IU; Rehman NU; Ali I; Ajmal N; Ahsan MJ
Molecules; 2023 Feb; 28(4):. PubMed ID: 36838935
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of cisplatin and [Pt(dach)Cl2] on the activity of phospholipase A2.
Radisavljević M; Kamčeva T; Bugarčić ŽD; Petković M
J Enzyme Inhib Med Chem; 2013 Aug; 28(4):651-60. PubMed ID: 22424180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
